Copy number variation in schizophrenia in Sweden

Molecular Psychiatry

Volumn 19, Issue 7, 2014, Pages 762-773

  Szatkiewicz, J P ^a   O'Dushlaine, C ^b   Chen, G ^a   Chambert, K ^b   Moran, J L ^b   Neale, B M ^b   Fromer, M ^c   Ruderfer, D ^c   Akterin, S ^d   Bergen, S E ^b,d   Kahler A ^d   Magnusson, P K E ^d   Kim, Y ^a   Crowley, J J ^a   Rees, E ^e   Kirov, G ^e   O'Donovan, M C ^e   Owen, M J ^e   Walters, J ^e   Scolnick, E ^b   Sklar, P ^c   Purcell, S ^b,c   Hultman, C M ^d   McCarroll, S A ^b,f   Sullivan, P F ^a,d   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; MICRORNA;

ADULT; ARTICLE; BLOOM SYNDROME; CALCIUM SIGNALING; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME DUPLICATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOPLASM; FEMALE; GENE DELETION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; META ANALYSIS (TOPIC); MITOCHONDRIAL GENE; MITOCHONDRION; PHENOTYPE; PLEIOTROPY; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEGMENTAL DUPLICATION; SIGNAL TRANSDUCTION; SWEDEN; CASE CONTROL STUDY; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SWEDEN;

EID: 84903649108     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.40     Document Type: Article

References (68)

1. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-1131.
2. World Health Organization. The Global Burden of Disease: 2004 Update. WHO Press: Geneva, Switerland, 2008.
3. Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull 2004; 30: 279-293.
4. Lichtenstein P, Sullivan PF, Cnattingius S, Gatz M, Johansson S, Carlström E et al. The Swedish Twin Registry in the third millennium-an update. Twin Res Hum Genet 2006; 9: 875-882.
5. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic influences for schizophrenia and bipolar disorder: a population-based study of 2 million nuclear families. Lancet 2009; 373: 234-239.
6. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-1192.
7. Ripke S, Chambert K, Moran JL, Kähler AK, Akterin S, Bergen SE et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
8. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D et al. Genomewide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 2012; 18: 708-712.
9. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genomewide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
10. Levinson D.F, Duan J, Oh S, Wang K, Sanders AR, Shi J et al. Copy number variants in schizophrenia: Confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011; 168: 302-316.
11. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012; 148: 1223-1241.
12. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-153.
13. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537-551.
14. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185-190.
15. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543.
16. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009; 18: 1497-1503.
17. Buizer-Voskamp JE, Strengman E, Sabatti C, Stefansson H, Vorstman JA, Ophoff RA et al. Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients. Biol Psychiatry 2011; 70: 655-662.
18. Malhotra D, McCarthy S, Michaelson JJ, Vacic V, Burdick KE, Yoon S et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011; 72: 951-963.
19. Szatkiewicz JP, Neale BM, O'Dushlaine C, Fromer M, Goldstein JI, Moran JL et al. Detecting large copy number variants using exome genotyping arrays. Mol Psychiatry 2013; 18: 1178-1184.
20. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241.
21. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genomewide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared to bipolar disorder. Mol Psychiatry 2012; 17: 880-886.
22. Kristjansson E, Allebeck P, Wistedt B. Validity of the diagnosis of schizophrenia in a psychiatric inpatient register. Nordisk Psykiatrik Tidsskrift 1987; 41: 229-234.
23. Dalman C, Broms J, Cullberg J, Allebeck P. Young cases of schizophrenia identified in a national inpatient register-are the diagnoses valid? Soc Psychiatry Psychiatr Epidemiol 2002; 37: 527-531.
24. Hultman CM, Sparen P, Takei N, Murray RM, Cnattingius S. Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ 1999; 318: 421-426.
25. Zammit S, Allebeck P, Dalman C, Lundberg I, Hemmingsson T, Lewis G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry 2003; 160: 2216-2221.
26. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344: 808-814.
27. Hansson LE, Nyrén O, Hsing AW, Bergström R, Josefsson S, Chow WH et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-249.
28. Kendler KS. The super-normal control group in psychiatric genetics: possible artifactual evidence for coaggregation. Psychiatr Genet 1990; 1: 45-53.
29. Schwartz S, Susser E. The use of well controls: an unhealthy practice in psychiatric research. Psychol Med 2010; 41: 1-6.
30. Hartge P. Participation in population studies. Epidemiology 2006; 17: 252-254.
31. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 2006; 163: 197-203.
32. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 2008; 40: 1253-1260.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007; 81: 559-575.
34. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2011.
35. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D et al. Multiple recurnrent de novo CNVs, including duplications of the 7q11.23 Williams Syndrome region, are strongly associated with autism. Neuron 2011; 70: 863-885.
36. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43: 838-846.
37. Cox D. The continuity correction. Biometrika 1970; 57: 217-219.
38. Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S et al. Ensembl 2013. Nucleic Acids Res 2013; 41: D48-D55.
39. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2: e141.
40. Raychaudhuri S, Altshuler D, Sklar P, Purcell S, Daly MJ, Korn JM et al. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet 2010; 6: e1001097.
41. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012; 40: D109-D114.
42. GO Project. The Gene Ontology: enhancements for 2011. Nucleic Acids Res 2012; 40: D559-D564.
43. Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic acids Res 2010; 38: D204-D210.
44. Jupe S, Akkerman JW, Soranzo N, Ouwehand WH. Reactome-a curated knowledgebase of biological pathways: megakaryocytes and platelets. J Thromb Haemost 2012; 10: 2399-2402.
45. McKusick VA. Mendelian inheritance in man and its online version, OMIM. Am J Hum Genet 2007; 80: 588-604.
46. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
47. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011; 146: 247-261.
48. Ruano D, Abecasis GR, Glaser B, Lips ES, Cornelisse LN, de Jong AP et al. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet 2010; 86: 113-125.
49. Croning MD, Marshall MC, McLaren P, Armstrong JD, Grant SG. G2Cdb: the Genes to Cognition database. Nucleic Acids Res 2009; 37: D846-D851.
50. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011; 1380: 42-77.
51. Chiurazzi P, Schwartz CE, Gecz J, Neri G. XLMR genes: update 2007. Eur J Hum Genet 2008; 16: 422-434.
52. Inlow JK, Restifo LL. Molecular and comparative genetics of mental retardation. Genetics 2004; 166: 835-881.
53. Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011; 478: 57-63.
54. Blake JA, Bult CJ,Kadin JA, Richardson JE, Eppig JT. The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Res 2011; 39: D842-D848.
55. Maddatu TP, Grubb SC, Bult CJ, Bogue MA. Mouse Phenome Database (MPD). Nucleic Acids Res 2011; 37: D720-D730.
56. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008; 134: 112-123.
57. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
58. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
59. International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
60. Ruderfer DM, Chambert K, Moran J, Talkowski M, Chen ES, Gigek C et al. Mosaic copy number variation in schizophrenia. Eur J Hum Genet 2013; 21: 1007-1011.
61. Rees E, Kirov G, Sanders A, Walters JT, Chambert KD, Shi J et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry 2013; 19: 37-40.
62. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 2012; 13: 293-307.
63. Robicsek O, Karry R, Petit I, Salman-Kesner N, Müller FJ, Klein E et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 2013; 18: 1067-1076.
64. Ferreira M, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J et al. Collaborative genome-wide association analysis of 10 596 individuals supports a role for Ankyrin-G (ANK3) and the alpha-1C subunit of the L-type voltage-gated calcium channel (CACNA1C) in bipolar disorder. Nat Genet 2008; 40: 1056-1058.
65. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013; 381: 1654-1662.
66. Murray RM, Jones PB, Susser E, van Os J, Cannon M. The Epidemiology of Schizophrenia. Cambridge University Press: Cambridge, UK, 2003.
67. Handsaker RE, Korn JM, Nemesh J, McCarroll SA. Discovery and genotyping of genome structural polymorphism by sequencing on a population scale. Nat Genet 2011; 43: 269-276.
68. McCarroll SA, Kuruvilla FG, Korn JM, Cawley S, Nemesh J, Wysoker A et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008; 40: 1166-1174.